FDA Approves Datroway for Pretreated Advanced Breast Cancer

(MedPage Today) -- The FDA approved datopotamab deruxtecan (Datroway) for adults with unresectable or metastatic, hormone receptor (HR)-positive/HER2-negative breast cancer who have received prior endocrine-based therapy and chemotherapy for unresectable...